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ABSTRACT:
Red raspberries contain principally anthocyanins and ellagitan-
nins. After ingestion of raspberries by humans, trace levels of
anthocyanins, absorbed in the upper gastrointestinal tract, are
excreted in urine in amounts corresponding to <0.1% of intake.
Urine also contains urolithin-O-glucuronides derived from colonic
metabolism of the ellagitannins. Raspberry feedings with ileosto-
mists show that substantial amounts of the anthocyanin and ella-
gitannin intake are excreted in ileal fluid. In subjects with an intact
functioning colon, these compounds would pass to the large in-
testine. The aim of this study was to identify raspberry-derived
phenolic acid catabolites that form in the colon and those that are
subsequently excreted in urine. In vitro anaerobic incubation of
ellagitannins with fecal suspensions demonstrated conversion to
ellagic acid and several urolithins. Fecal suspensions converted
80% of added ellagic acid to urolithins. In vivo, urolithins are
excreted in urine as O-glucuronides, not aglycones, indicating that
the colonic microflora convert ellagitannins to urolithins, whereas
glucuronidation occurs in the wall of the large intestine and/or
postabsorption in the liver. Unlike ellagitannins, raspberry antho-
cyanins were converted in vitro to phenolic acids by anaerobic
fecal suspensions. Urinary excretion of phenolic acids after inges-
tion of raspberries indicates that after formation in the colon some
phenolic acids undergo phase II metabolism, resulting in the for-
mation of products that do not accumulate when anthocyanins are
degraded in fecal suspensions. There is a growing realization that
colonic catabolites such as phenolic acids and urolithins may have
important roles in the protective effects of a fruit- and vegetable-
rich diet.
Introduction
There is evidence from a diversity of sources that a berry-rich
diet offers potential protective effects on health (Beattie et al.,
2005; Del Rio et al., 2010) with daily consumption of red raspberry
juice for 12 weeks by hamsters consuming an atherogenic diet
reducing aortic lipid deposition by 90% (Rouanet et al., 2010).
Red raspberries contain the ellagitannins sanguiin H-6 and lam-
bertianin C as well as a characteristic spectrum of anthocyanins,
the major constituents being cyanidin-3-O-sophoroside, cyanidin-
3-O-(2-O-glucosyl)rutinoside, and cyanidin-3-O-glucoside with
smaller quantities of cyanidin-3-O-rutinoside, cyanidin-3-O-(2-O-
xylosyl)rutinoside pelargonidin-3-O-sophoroside, pelargonidin-3-
(2-O-glucosyl)rutinoside, pelargonidin-3-O-glucoside, and pelar-
gonidin-3-O-rutinoside (Mullen et al., 2002; Borges et al., 2010).
There is evidence linking intake of ellagitannins to health benefits.
This finding is based principally on research with pomegranate
juice, which contains ellagitannins in the form of punicalins and
punicalagin (Aviram et al., 2000; Pantuck et al., 2006; Rosenblat et
al., 2006; Belal et al., 2009; Larrosa et al., 2010; Verzelloni et al.,
2011).
In our earlier study, after oral ingestion of 300 g of raspberries by
human subjects, no anthocyanins were detected in plasma and 0.1%
of intake was excreted in urine 0 to 7 h after ingestion, indicating
low-level absorption in the proximal gastrointestinal tract (González-
Barrio et al., 2010). No ellagitannins were detected in either plasma or
urine collected after raspberry ingestion. However, there was evidence
of colonic catabolism of ellagitannins with the appearance of urolithin
A-O-glucuronide, two of its isomers, and urolithin B-O-glucuronide
in urine collected 7 to 48 h after raspberry consumption. A parallel
feeding study, in which 300 g of raspberries were ingested by ileos-
tomists, also detected trace amounts of urinary anthocyanins, but in
keeping with their formation in the colon, urolithins were not excreted
in urine. Ileal fluid collected after raspberry consumption contained
40% of the anthocyanin intake and 23% of the ingested sanguiin H-6.
In healthy subjects with a functioning colon, these compounds would
pass from the small to the large intestine where they would be subject
to the action of microbiota (González-Barrio et al., 2010).
This article reports on further studies on the fate of ellagitannins
and anthocyanins in the colon in which, after raspberry consumption
by healthy humans, urinary excretion of phenolic acid catabolites was
monitored. In addition, products formed during anaerobic in vitro
fecal fermentation of 1) raspberry anthocyanins, 2) the ellagitannin
punicalagin, and 3) ellagic acid were investigated.
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Materials and Methods
Raspberries and Chemicals. Raspberry plants cv. Glen Ample obtained
from a commercial grower in Angus, UK, were used in the feeding study with
humans. Raspberry juice, rich in anthocyanins but containing only traces of
ellagitannins and other minor compounds including hydroxycinnamic acid
derivatives and flavonols (supplied by Ella Drinks Ltd., Alloa, Clackmannon-
shire, Scotland), was freeze-dried, and the resultant powder was used in in vitro
incubations with fecal slurries. Cyanidin-3-O-glucoside was purchased from
Apin Chemicals (Abingdon, Oxford, UK), cyanidin-3-O-sambubioside-5-O-
glucoside was from Polyphenols (Sandnes, Norway), and phenolic acids were
from Sigma-Aldrich (Poole, Dorset, UK), Thermo Fisher Scientific (Leices-
tershire, UK), Extrasynthese (Genay, France), and AASC Ltd. (Southampton,
Hampshire, UK). Punicalagin was supplied by ChromaDex (Irvine, CA), and
urolithins A and B were a generous gift from Dr. Navindra Seeram (University
of Rhode Island, Kingston, RI). HPLC-grade solvents were obtained from
Rathburn Chemicals (Walkerburn, Peebleshire, UK). Formic acid, sodium
diethyldiothiocarbamate, tryptone, and resazurin were purchased from Sigma-
Aldrich. All chemicals and reagents used in the preparation of buffers and
macromineral, micromineral, and reducing solutions were obtained from Sigma-
Aldrich, Thermo Fisher Scientific, and BDH Laboratory Supplies (Poole, UK).
Human Feeding Studies. The Glasgow Royal Infirmary Research Ethics
Committee and the Glasgow University Ethical Committee approved the study
protocol. Nine healthy humans (four female and five male) were recruited and
gave their written consent to participate in the study. They were nonsmokers,
were not taking medication, and were aged between 25 and 31 years. Subjects
were required to follow a diet low in (poly)phenolic compounds by avoiding
fruits and vegetables, nuts, high-fiber products, and beverages such as tea,
coffee, and fruit juices as well as to abstain from consuming alcohol 60 h
before the beginning of the study. After an overnight fast, the volunteers
consumed 300 g of raspberries and after 3 h followed the low phenolic diet
until the final urine sample was collected. All urine excreted 24 h before and
over five time periods (0–4, 4–7, 7–24, 24–32, and 32–48 h) after raspberry
consumption was collected. After volumes of urine were recorded, aliquots
were stored at 80°C until analysis.
Human Fecal Samples. For the in vitro fecal incubation experiments,
healthy subjects who participated in the study had a normal diet, were non-
smokers, were aged from 22 to 30 years, had no digestive disease, and had not
received antibiotics for at least 6 months before the study. The donors followed
the special diet low in (poly)phenolic compounds for 60 h before feces
collection. Fecal samples, collected by the donors in a special plastic tub
containing an AnaeroGen sacket (Oxoid Ltd., Cambridge, UK) to generate
anaerobic conditions, were processed within 1 h of passage.
Fermentation Medium. The fermentation medium was prepared as de-
scribed by Jaganath et al. (2009). In brief, 2 g of tryptone was mixed in 400 ml
of distilled water and 100 l of micromineral solutions (consisting of 13.2 g of
CaCl2  2H2O, 10 g of MnCl2  4H2O, 1 g of CoCl2  6H2O, 8 g of FeCl3  6H2O,
and distilled water up to 100 ml), 200 ml of buffer (2 g of NH4HCO3, 17.5 g
of NaHCO3, and distilled water up to 500 ml), 200 ml of macromineral
solution (2.85 g of Na2HPO4, 3.1 g of KH2PO4, 0.3 g of MgSO4  7H2O, and
distilled water up to 500 ml), and 1 ml of 1% (w/v) of resazurin solution (a
redox indicator). The medium was adjusted to pH 7 using HCl, boiled, and
allowed to cool under oxygen-free nitrogen (OFN) to remove oxygen. Reduc-
ing solution (312 mg of cysteine hydrochloride, 2 ml of 1 M NaOH, 312 mg
of Na2S  9H2O, and distilled water up to 50 ml) was added at 0.5 ml/10 ml
of medium after which the solution was purged with OFN until anaerobic
conditions.
In Vitro Incubations. Samples of freshly voided human feces were ho-
mogenized with phosphate buffer to obtain 32% fecal suspensions. Five
milliliters of suspension was added to 44 ml of the prereduced fermentation
medium and 1 ml of substrate in a 100-ml McCartney bottle. Raspberry
anthocyanins, punicalagin, and ellagic acid, in the presence of 0.5 g of glucose,
were added to fecal suspensions. Blank fecal suspensions without the addition
of substrate were incubated simultaneously. To distinguish between enzy-
matic and chemical degradation, substrates were also incubated in the
presence of heat-inactivated microflora (100°C, 1 h) obtained from one of
the donors.
After the substrates were added, the fermentation bottles were purged with
OFN, sealed airtight, and placed horizontally in a shaking water bath shaking
at 60 stokes/min and protected from the light. The fermentation bottles were
incubated at 37°C over 48 h (raspberry anthocyanins) or 72 h (punicalagin and
ellagic acid), aiming to simulate the conditions in the colonic lumen (Edwards
et al., 1996). Aliquots of fecal suspensions (6 ml) collected after 0, 2, 4, 6, 24,
and 48 h (raspberry anthocyanin incubations) and after 0, 2, 5, 24, 48, and 72 h
of (punicalagin and ellagic acid incubations) were stored at 80°C before
analysis. The average initial pH of the cultures was 7.2 and at the end of the
incubation period, this had dropped to pH 5.8, pH 6.5, and pH 6.3 after
raspberry anthocyanin, punicalagin, and ellagic acid incubations, respectively.
Purification of Fecal Suspension Incubations. Anthocyanins, punicalagin,
ellagic acid, and urolithins in fecal suspensions were purified using a SDB-L
cartridge (500 mg/6 ml, Strata; Phenomenex, Macclesfield, Cheshire, UK)
before analysis by HPLC-PDA-MS2. Aliquots of fecal suspensions (1 ml) were
added to 5 ml of 1% aqueous formic acid and vortexed and centrifuged at
4000g for 5 min at 4°C. The supernatant obtained was loaded on to a
preconditioned SDB-L cartridge, which was washed with 5 ml of 1% aqueous
formic acid before elution of anthocyanins, punicalagin, ellagic acid, and
urolithins with 3.5 ml of MeOH acidified with 1% formic. The methanolic
phase was reduced to dryness under nitrogen, dissolved in 100 l of 1% formic
acid in MeOH and 200 l of 1% aqueous formic acid, vortex-mixed, centri-
fuged at 16,110g for 10 min at 4°C, and analyzed by HPLC-PDA-MS2. Blank
fecal suspensions were spiked with known amounts of cyanidin-3-O-sambu-
bioside-5-O-glucoside, ellagic acid, punicalagin, and urolithin A to assess
recovery efficiencies. The solid phase extraction gave a recovery rate of 75 to
80% for anthocyanins, 98 to 102% for punicalagin, 60 to 62% for ellagic acid,
and 85 to 87% for urolithin A.
Purification of Phenolic Acids in Urine and Fecal Suspensions. Phenolic
acid purification, derivatization, and analysis of urine were adapted from
TABLE 1
Quantities of phenolic acids excreted in urine by humans 24 h before and after the consumption of 300 g of raspberries
Data expressed as mean values  S.E. (n  8).
Urinary Phenolic Acids Control 0–24 h Subjects withSignificant Increase
mol
4-Hydroxybenzoic acid 6.4  1.1 7.4  1.5 1 of 8
4-Hydroxymandelic acid 10  2 15  1* 4 of 8
3-Methoxy-4-hydroxymandelic acid 13  2 15  1 3 of 8
3,4-Dihydroxyphenylacetic acid 2.0  0.6 3.4  0.3* 4 of 8
4-Hydroxyphenylacetic acid 65  12 87  7 3 of 8
3-(3-Hydroxyphenyl)hydracrylic acid 16  6 14  4 2 of 8
3-(4-Hydroxyphenyl)lactic acid 3.8  0.7 6.5  0.8* 2 of 8
3-Methoxy-4-hydroxyphenylacetic acid 18  2 17  2 1 of 8
4-Hydroxyhippuric acid 28  5 50  9* 4 of 8
Hippuric acid 589  95 1390  134* 6 of 8
Total 751  108 1606  137* 6 of 8
Total without hippuric acid 163  24 216  17 2 of 8
* Denotes that mean values increased significantly after raspberry consumption (P  0.05).
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Roowi et al. (2010) with some modifications. A 30-g internal standard of
2,4,5-trimethoxycinnamic acid was added to 1 ml of urine. Samples were
acidified by adding 65 l of 1 M HCl and partitioned three times against
1.5-ml volumes of ethyl acetate. The upper organic phases were combined,
transferred to an amber glass vial and dried at 37°C under a stream of nitrogen.
A 200-l volume of dichloromethane added to rinse the wall of the vials was
dried under nitrogen at 37°C. Derivatization reagent [50 l of N,O-bis(tim-
ethylsilyl)trifluoroacetamide  10% trimethylchlorosilane] was added to the
vials, which were flushed with a gentle flow of nitrogen before sealing.
Samples were heated at 70°C for 4 h with vortexing every 30 min to achieve
complete silylation. Anhydrous hexane (350 l) was added to each sample
before analysis by GC-MS.
Purification and analysis of phenolic acids in fecal suspensions was per-
formed as follows. In brief, 1 ml of fecal suspension was added to 4 ml of
aqueous 0.2 M HCl, and the mixture was centrifuged at 4000g for 5 min at 4°C.
2,4,5-Trimethoxycinnamic acid was added to the supernatant, which was
loaded onto a preconditioned 500-mg SDB-L cartridge, which was then
washed with 0.1 M HCl before the phenolic acids were eluted with ethyl
acetate. The residual aqueous phase was separated from the organic phase by
centrifugation at 4000g for 10 min at 4°C. The ethyl acetate extract was then
transferred to an amber glass and dried at 37°C under a slight stream of
nitrogen. Samples were further dried by the addition and evaporation of
dichloromethane, and the dried extract was derivatized as described for urine
samples.
Qualitative and Quantitative Analysis by GC-MS. Derivatized phenolic
acids in urine and fecal suspensions were analyzed on a trace gas chromato-
graph interfaced to a DSQ mass spectrometer equipped with a split/splitless
injector and an AI3000 autosampler (Thermo Fisher Scientific, Hemel Hamp-
sted, UK). Samples (1 l) were injected in split mode with a 25:1 ratio. The
inlet temperature was maintained at 220°C. The oven was programmed from
40°to 160°C at 20°C/min, to 200°C at 1.5°C/min, and to 250°C at 10°C/min to
a final temperature of 300°C at 40°C/min, held for 5 min. The transfer line was
maintained at 310°C. The helium carrier gas flow rate was 1.2 ml/min. Data
acquisition was performed in the positive ionization mode in full scan (m/z
50–470) with an ionization energy of 70 eV, from 5 to 35 min. Acquisition and
analysis of GC-MS data were performed with Xcalibur version 2. Phenolic
acids were identified by comparison with the retention times and mass spectra
of authentic standards. Quantification was based on 2.5- to 50-ng calibration
curves constructed for a set of phenolic acid standards that were derivatized
and analyzed (R2  	0.96).
Qualitative and Quantitative Analysis by HPLC-PDA-MS2. Urine and
purified fecal samples were analyzed on a Surveyor HPLC system composed
of an HPLC pump, a PDA detector, scanning from 200 to 700 nm, and an
autosampler cooled to 4°C (Thermo Fisher Scientific). Separations of puni-
calagin, ellagic acid, urolithins, and anthocyanins were performed using a
Synergi 4-m RP-POLAR reverse-phase column (80 Å, 250 
 4.6 mm i.d.;
Phenomenex, Macclesfield, UK), and maintained at 40°C. The mobile phase,
pumped at a flow rate of 1 ml/min, was 0.1% formic acid and 100% MeOH,
establishing a linear gradient from 10 to 40% MeOH over 60 min to analyze
anthocyanins and from 10 to 65% MeOH over 50 min to analyze punicalagin,
ellagic acid, and urolithins. After passing through the flow cell of the PDA
detector, the column elute was split, and 0.3 ml/min was directed to a LCQ
DecaXP ion trap mass spectrometer fitted with an electrospray interface in
positive mode for anthocyanins and in negative mode for ellagitannins, ellagic
acid, and urolithins. Analyses were performed using full scan, data-dependent
FIG. 1. Anaerobic degradation of raspberry anthocyanins in the presence of heat-
inactivated (E) and active microflora (F) in fecal suspensions. Bars represent
S.E.M. (n  6). The initial concentration of anthocyanins glycosides was 100 M.
TABLE 2
Mean concentration of phenolic acids detected in fecal suspensions from six donors incubated for 0, 6, 24, and 48 h with raspberry anthocyanins at a concentration
of 100 M
Data expressed as mean values  S.E. (n  6).
Phenolic Acids Incubationsa 0 h 6 h 24 h 48 h
mol
Catechol Blank N.D. N.D. N.D. N.D.
Treated N.D. 2.7  0.7* 2.7  1.0* 2.9  1.3*
Resorcinol Blank N.D. N.D. N.D. N.D.
Treated N.D. 1.2  0.4* 1.4  0.4* 1.4  0.5*
Pyrogallol Blank N.D. N.D. N.D. N.D.
Treated N.D. 3.0  1.6* 2.3  1.3* 2.3  1.6*
4-Hydroxybenzoic acid Blank N.D. N.D. N.D. N.D.
Treated 5.1  0.4* 13  1.4* 15  1.5* 14  1.6*
3,4-Dihydroxybenzoic acid Blank N.D. N.D. N.D. N.D.
Treated 7.4  0.4* 8.3  1.0* 8.7  1.2* 11  1.8*
Tyrosol Blank N.D. N.D. N.D. N.D.
Treated 2.6  0.2* 15  2.2* 17  2.1* 15  2*
3-Phenyllactic acid Blank 1.7  1.0 52  18 50  22 41  19
Treated 3.8  1.2 40  7.6 82  15 91  25
3-(4-Hydroxyphenyl)lactic acid Blank 0.2  0.2 10  3.1 14  4.6 14  4.7
Treated 1.0  0.5 15  1.5 29  3.2* 31  7.0
3-(3-Hydroxyphenyl)propionic acid Blank 1.1  1.1 1.0  1.0 1.1  0.8 1.3  1.0
Treated 2.0  1.0 13  1.9* 13  2.3* 12  2.6*
3-(4-Hydroxyphenyl)propionic acid Blank 5.3  4 7.9  6.2 10  7.1 11  7.5
Treated 6.8  3.7 13  5.9 16  5.3 15  5.2
3-(3,4-Dihydroxyphenyl)propionic acid Blank N.D. N.D. N.D. N.D.
Treated N.D. 2.3  2.3 2.7  2.7 2.1  2.1
N.D., not detected.
* Significantly higher than blank incubations values at P  0.05.
a Treated and blank incubations, with or without the addition of raspberry anthocyanins, respectively.
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MS2 scanning from m/z 150 to 1500. With the electrospray interface in positive
ionization mode, the capillary temperature was 300°C, sheath gas was 50 units,
auxiliary gas was 35 units, and source voltage was 2 kV. For negative
ionization, the capillary temperature was 200°C, sheath gas was 60 units,
auxiliary gas was 20 units, and source voltage was 6 kV. Anthocyanins were
quantified by reference to a 1- to 1000-ng cyanidin-3-O-glucoside calibration
curve (R2  0.999) at 520 nm. Punicalagin and ellagic acid were quantified
against standard curves for reference compounds at 280 nm (10–1500 ng,
R2  0.997) and 365 nm (1–1000 ng, R2  0.999), respectively. Urolithin A
and urolithin B were quantified against standards at 305 nm (0.4–800 ng,
R2  0.998), whereas isourolithin A and urolithin C were quantified at 305 nm
in urolithin A equivalents. These compounds were identified according to their
absorbance and MS spectra based on data reported previously (Espín et al.,
2007; Borges et al., 2010; González-Barrio et al., 2011).
Statistical Analyses. All samples were analyzed in triplicate, and the
quantitative estimates represent mean values  S.E. Data were subjected to
statistical analysis of variance. Normality of variances was tested by the
Shapiro-Wilk test, before the analysis of variance was determined. Statistical
analyses were performed using SPSS version 14.0 (SPSS Inc., Chicago, IL) for
Windows.
Results
Analysis of Raspberries. The analysis of the raspberries used in
the feeding study has been described previously (González-Barrio et
al., 2010). Each 300-g serving contained a total of 204 mol of
anthocyanins and 123 mol of ellagitannins of which 82% was
sanguiin H-6. The total ellagic acid (free and conjugated) content was
17 mol.
Urinary Excretion of Phenolic Acids after the Consumption of
Raspberries. Data on the mean quantities of 10 phenolic acids in
urine collected over 24-h periods before and after the ingestion of
raspberries by eight subjects are summarized in Table 1. These phe-
nolic acids were identified on the basis of GC-MS analysis by com-
parison with the retention times and mass spectra of authentic stan-
dards (Supplemental Table 1). All the phenolic acids were present in
urine collected both before and after raspberry intake. Small but
significant increases in 4-hydroxymandelic acid, 3,4-dihydroxyphe-
nylacetic acid, 3-(4-hydroxyphenyl)lactic acid, 4-hydroxyhippuric
acid, and hippuric acid were observed after raspberry consumption.
Excretion of some of the other phenolic acids may have increased
after raspberry intake, but because of their presence in control sam-
ples, the increases were not statistically significant. This is com-
pounded by substantial differences in the phenolic acid excretion
profile of the individual volunteers, which reflect variations in their
colonic microflora. These can be assessed by consulting the informa-
tion in Table 1 on instances for which significant increases in the
excretion of specific phenolic acids were observed with some but not
all eight volunteers. More detailed information on the phenolic acid
excretion pattern of the individual volunteers can be found in Sup-
plemental Table 2.
In preliminary studies, some urine samples were treated with -glu-
curonidase and sulfatase enzymes at different concentrations (20, 50,
100, and 200 U of sulfatase H-2 from 2150 U of Helix pomatia, which
contains residual -glucuronidase activity) before analysis by GC-
MS. This treatment did not significantly increase the quantities of
phenolic acids detected nor did it change the phenolic acid profiles,
which indicates that the phenolic acids monitored in this study are
excreted principally as free acids and not as glucuronide or sulfate
conjugates.
Anaerobic Degradation of Raspberry Anthocyanins by Fecal
Suspensions. The two main anthocyanins identified by HPLC-PDA-
MS2 in the raspberry juice extract were cyanidin-3-O-sophoroside
(m/z 6113 287) and cyanidin-3-O-(2-O-glucosyl)rutinoside (m/z
7573 611, 287), representing 50 and 30% of the total anthocyanins,
respectively. In addition to these compounds, other minor anthocya-
nins were identified, including cyanidin-3-O-glucoside (m/z 4493 287),
pelargonidin-3-O-sophoroside (m/z 5953 271), cyanidin-3-O-ruti-
noside (m/z 5953 287), and pelargonidin-3-O-(2-O-glucosyl)ruti-
noside (m/z 7413 595, 271). HPLC-PDA-MS2 analysis of fecal
suspensions incubated with the raspberry anthocyanin extract at a
concentration of 100 M showed a time-dependent loss of the antho-
cyanins. Nonetheless, 	20% still remained intact after 48 h (Fig. 1).
FIG. 2. GC-MS traces of phenolic acids in fecal suspensions of healthy donors
incubated with raspberry anthocyanins, collected at the times indicated. 1, catechol;
2, resorcinol; 3, pyrogallol; 4, tyrosyl; 5, 3-phenyllactic acid; 6, 4-hydroxybenzoic
acid; 7, 4-hydroxyphenylacetic acid; 8, 3-(3-hydroxyphenyl)propionic acid; 9,
3-(4-hydroxyphenyl)propionic acid; and 10, 3-(4-hydroxyphenyl)lactic acid.
FIG. 3. Anaerobic metabolism of punicalagin to ellagic acid and urolithins in fecal
suspensions. Bars represent S.E.M. (n  5). The initial concentration of punicalagin
was 100 M.
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The individual anthocyanins were degraded at a similar rate (data
not shown). To distinguish between enzymatic and chemical deg-
radation, the raspberry anthocyanin extract was also incubated with
fecal suspensions previously deactivated by treatment at 100°C for
1 h. Heat-treated fecal suspensions did not degrade the anthocya-
nins (Fig. 1), demonstrating that the losses observed with the
activated suspensions were a consequence of the enzymatic activ-
ity of the colonic microbiota.
In addition to analyzing the anthocyanin content of the fecal incu-
bations, phenolic acid levels were determined by GC-MS. The data
obtained are presented in Table 2. Typical GC traces are illustrated in
Fig. 2, whereas retention time data and mass spectra of the trimeth-
ylsilyl derivatives can be found in Supplemental Table 1. Although
the concentrations of 3-phenyllactic acid and 3-(4-hydroxyphenyl)
propionic acid rose, there was a high background, and the increases
were not statistically significant, in contrast to the increases in cate-
chol, resorcinol, pyrogallol, 4-hydroxybenzoic acid, 3,4-dihydroxy-
benzoic acid, tyrosol, 3-(3-hydroxyphenyl)propionic acid, and
3-(3,4-dihydroxyphenyl)propionic acid. The concentration of
3-(4-hydroxyphenyl)lactic acid also increased but because of the
high background, this increase was significant only at the 24-h
time point (Table 2). Incubations with heat-treated fecal suspen-
sions, in keeping with their inability to degrade the raspberry
anthocyanins, did not accumulate phenolic acid, demonstrating the
role of the colonic microbiota in the formation of these catabolites
(data not shown).
Anaerobic Degradation of Ellagitannins Incubated with Fecal
Suspensions. The raspberry ellagitannins sanguiin H-6 and lamber-
tianin C were not readily available in quantity so fecal incubations
from five volunteers were performed with punicalagin, a structurally
similar ellagitannin. Punicalagin is found in pomegranates and, like
sanguiin H-6 and lambertianin C, can be hydrolyzed to yield ellagic
acid, which is converted to urolithins (Clifford and Scalbert, 2000;
Cerdá et al., 2005; Crozier et al., 2009). Although punicalagin was
added to the incubations at a concentration of 100 M, only 50 M
was detected at the beginning of the incubation period. Ellagic acid
was also detected at the 0-h time point, suggesting that the reduction
in initial punicalagin concentration may, in part, be attributed to
hydrolysis of the ellagitannin-releasing ellagic acid (Fig. 3). Ellagic
acid declined between the 0- and 5-h time points and thereafter was
present, albeit in low concentrations. The concentration of total uro-
lithins increased over the incubation period, reaching a plateau after
48 to 72 h. The concentration of punicalagin declined for the first 5 h
of incubation after which it remained stable at 20 M (Fig. 3).
As with the excretion of urinary phenolic acids, there was marked
variation in both the rate of decline of punicalagin and the appearance
of ellagic acid and urolithins in fecal suspensions obtained from
different volunteers (Table 3). Residual punicalagin concentrations at
the end of the 72-h incubation period were 26, 21, 13, 15, and 1.3 M,
whereas the final total urolithin concentrations were 27.4, 2.9, 1.3,
0.3, and 0 M. The type of urolithin accumulated also varied sub-
stantially with low amounts of urolithins A and C being most prev-
TABLE 3
In vitro anaerobic metabolism of punicalagin to ellagic acid and urolithins in fecal suspensions from five donors
Quantities of substrate and products detected in fecal samples taken 0, 6, 24, and 48 h after incubation of punicalagin at a concentration 100 M. Data are expressed as mean values of
individual donors  S.E. (n  3).
Donor and Compounds 0 h 2 h 5 h 24 h 48 h 72 h
M
I
Punicalagin 60  2 67  2 33  1 27  1 19  8 13  1
Ellagic acid 2.7  0.2 2.9  0.3 0.8  0.0 0.6  0.2 0.4  0.1 0.3  0.0
Urolithin C N.D. N.D. 0.3  0.0 0.6  0.0 0.6  0.0 0.3  0.0
Isourolithin A N.D. N.D. N.D. N.D. N.D. N.D.
Urolithin A N.D. N.D. N.D. N.D. N.D. N.D.
Total urolithins N.D. N.D. 0.3  0.0 0.6  0.0 0.6  0.0 0.3  0.0
II
Punicalagin 44  0 52  2 20  0 24  0 25  2 21  9
Ellagic acid 3.1  0.1 2.7  0.3 0.4  0.0 N.D. N.D. N.D.
Urolithin C N.D. N.D. N.D. 1.4  0.0 1.6  0.1 N.D.
Isourolithin A N.D. N.D. N.D. N.D. N.D. N.D.
Urolithin A N.D. N.D. N.D. N.D. N.D. N.D.
Total urolithins N.D. N.D. N.D. 1.4  0.0 1.6  0.1 N.D.
III
Punicalagin 65  2 64  2 33  1 33  0 33  0 26  0.3
Ellagic acid 2.8  0.2 2.4  0.1 0.4  0.0 0.4  0.2 0.7  0.3 1.0  0.0
Urolithin C N.D. N.D. 1.3  0.1 1.3  0.0 1.3  0.1 1.3  0.1
Isourolithin A N.D. N.D. N.D. N.D. N.D. N.D.
Urolithin A N.D. N.D. N.D. N.D. N.D. N.D.
Total urolithins N.D. N.D. 1.3  0.1 1.3  0.0 1.3  0.1 1.3  0.1
IV
Punicalagin 46  6 22  0 5.8  0.3 1.9  0.1 1.1  0.5 1.3  0.9
Ellagic acid 2.6  0.9 0.9  0.0 0.2  0.0 0.3  0.0 0.1  0.0 0.1  0.0
Urolithin C N.D. N.D. 0.4  0.0 2.0  0.0 0.3  0.0 0.7  0.0
Isourolithin A N.D. N.D. N.D. 1.2  0.0 23  0.6 24  1.4
Urolithin A N.D. N.D. N.D. 1.2  0.0 2.9  0.1 3.1  0.2
Total urolithins N.D. N.D. 0.4  0.0 4.4  0.1 26  0.7 27  2
V
Punicalagin 60  4 21  0.3 13  0.7 16  2 14  3 15  3
Ellagic acid 2.7  0.5 0.7  0.0 0.6  0.1 0.2  0.0 0.2  0.1 0.2  0.0
Urolithin C N.D. N.D. 0.2  0.0 1.8  0.0 2.0  0.1 1.1  0.0
Isourolithin A N.D. N.D. N.D. N.D. N.D. N.D.
Urolithin A N.D. N.D. N.D. N.D. 0.8  0.0 1.8  0.0
Total urolithins N.D. N.D. 0.2  0.0 1.8  0.0 2.8  0.0 2.9  0.0
N.D., not detected.
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alent, whereas a high concentration of isourolithin A was produced
exclusively by donor IV (Table 3). Marked person-to-person varia-
tions were previously observed in the urinary excretion of urolithins
after consumption of raspberry and other ellagitannin-containing food
(Cerdá et al., 2005; González-Barrio et al., 2010).
In contrast to the production of urolithins, incubation of punicalagin
with fecal suspensions did not result in the synthesis of significant
amounts of phenolic acids.
Anaerobic Incubation of Ellagic Acid Fecal Suspensions. In
view of its role as an intermediate in the conversion of ellagitannins
to urolithins (Larrosa et al., 2006), ellagic acid was incubated with
fecal suspensions at a concentration of 50 M for periods of up to
72 h. At the 0-h time point, the ellagic acid concentration had declined
by 50%, possibly because of its limited solubility (Fig. 4). During the
initial phase of the incubation, ellagic acid declined further and after
5 h the mean concentration was 1.0 M. Urolithins began to appear
in the incubates after 5 h and thereafter rose rapidly, and the average
concentration after 72 h was 22 M compared with the initial mean
0-h ellagic acid concentration of 28 M. This result indicates an
80% conversion of ellagic acid to urolithins. As with the puni-
calagin incubations, there was much variation in the profile of uro-
lithins that were formed from ellagic acid with urolithin A, isouro-
lithin A, and urolithin C being detected in most incubations, whereas
the fecal suspension from one volunteer also produced urolithin B
(Table 4). These data are based on HPLC-PDA-MS2 analysis with
typical traces illustrated in Supplemental Figure 1). More detailed
information on the identification of urolithins on the basis of absor-
bance and mass spectra can be found in Supplemental Figure 2.
Discussion
In our earlier human feeding study in which subjects ingested 300 g
of raspberries, anthocyanins were detected in urine in amounts cor-
responding to 0.1% of intake. Urolithin-O-glucuronides, derived from
colonic breakdown of the ellagitannins sanguiin H-6 and lambertianin
C, were also excreted with much person-to-person variation in the
amounts (0–8.5% of ellagitannin intake) and the spectrum of urinary
urolithins, comprising the O-glucuronides of urolithin A, two isomers
of urolithin A and urolithin B. After an intake of 300 g of raspberry
by volunteers with an ileostomy, 23% of the ellagitannin intake was
detected in ileal fluid. In subjects with an intact functioning colon, the
ellagitannins would pass from the small to the large intestine where
they would be converted to urolithins by the colonic microflora
(González-Barrio et al., 2010). These events were investigated in
more detail in the current investigation.
The in vitro anaerobic metabolism of ellagitannins and ellagic acid
by fecal suspensions was investigated. The fecal suspensions con-
verted punicalagin to ellagic acid, urolithin A, isourolithin A, and
urolithin C with substantial variation in the profile obtained with the
individual fecal samples (Table 3; Fig. 3), reflecting the person-to-
person differences in the colonic microflora. Ellagic acid was readily
converted to urolithins by the fecal suspensions with yields of 80%
(Table 4; Fig. 4). Although formed in greater amounts than from
punicalagin, the type of urolithins that were produced was very similar
except for the additional presence of small amounts of urolithin B. In
these in vitro incubations, only urolithin aglycones were produced,
whereas in vivo urolithin-O-glucuronides are excreted in urine
(González-Barrio et al., 2010). This finding indicates that the colonic
microflora are responsible for the conversion of ellagitannins to
urolithins, probably by the pathway illustrated in Fig. 5, whereas
glucuronidation is a feature of phase II metabolism either in the wall
of the large intestine and/or after absorption in the liver. It is also of
interest to note that incubation of punicalagin and ellagic acid with the
fecal suspensions did not result in any significant increases in pheno-
lic acid so both substrates appear to be resistant to bacteria-mediated
ring fission.
In our earlier raspberry feedings with ileostomists, 40% of the
anthocyanin intake was detected in ileal fluid (González-Barrio et al.,
2010). The fate of these anthocyanins was investigated in the current
study 1) by monitoring the in vitro catabolism of raspberry anthocya-
nins when incubated with fecal suspensions and 2) by analyzing
phenolic acids excreted in urine collected from healthy subjects with
a functioning colon after raspberry consumption.
Incubation of the predominantly cyanidin-based raspberry anthocya-
nins with fecal suspensions for 48 h resulted in their partial degradation
by the colonic microflora. Because the incubations were not performed
under acidic conditions, it was surprising that 20% of the anthocyanins
remained intact at the end of the incubation period (Fig. 1). The in vitro
colonic microflora-mediated breakdown of the anthocyanins resulted in
the accumulation of significant quantities of catechol, resorcinol, pyro-
gallol, 4-hydroxybenzoic acid, 3,4-dihydroxybenzoic acid, tyrosol, 3-(3-
hydroxyphenyl)propionic acid, 3-(3,4-dihydroxyphenyl)propionic acid,
and 3-(4-hydroxyphenyl)lactic acid (Table 2). Analysis of urine after the
consumption of 300 g of raspberries by healthy volunteers enabled the
phase II metabolism of these phenolic acids to be evaluated during their
passage through the wall of the colon and transport through the circula-
tory system before excretion. As noted previously, ellagitannins and
ellagic acid were not converted in significant amounts to phenolic acids
in fecal suspensions so the urinary phenolics are in all probability derived
FIG. 4. Anaerobic metabolism of ellagic acid to urolithins in fecal suspensions.
Bars represent S.E.M. (n  4). The initial concentration of ellagic acid was 50 M.
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principally from the raspberry anthocyanins. After raspberry consump-
tion, significant increases were observed in urinary excretion of 4-
hydroxymandelic acid, 3,4-dihydroxyphenylacetic acid, 3-(4-
hydroxyphenyl)lactic acid, 4-hydroxyhippuric acid, and hippuric acid
(Table 1). Possible routes for the production of these phenolic acids, from
ring A and ring B during the C-ring fission of cyanidin skeleton, which
are in keeping with proposals of Aura (2008), are illustrated in Fig. 6.
It is likely that the colonic breakdown of cyanidin-based anthocya-
nins is more complex that the routes illustrated in Fig. 6. Excretion of
some of the other phenolic acids listed in Table 1 may have increased
after raspberry intake but because of their high background levels, the
increases were not statistically significant. This is further complicated
by the large differences in the phenolic acid excretion of the individ-
ual volunteers, which is a consequence of variations in their colonic
microflora, and the fact that some of the phenolic acids are produced
by additional routes from sources unrelated to the ingested cyanidin-
based anthocyanins. It is, for instance, well known that there are
pathways to hippuric acid from benzoic acid, quinic acids (Clifford et
al., 2000), tryptophan, tyrosine, and phenylalanine (Self et al., 1960;
Gruemer, 1961). Nonetheless, the elevated urinary excretion of hip-
puric acid occurring after raspberry consumption is likely to be
partially derived from anthocyanin degradation.
Monitoring the in vitro and in vivo fate of ellagitannins in the colon
is more straightforward than monitoring that of anthocyanins and
other flavonoids because they appear to be converted predominantly
to urolithins, which unlike phenolic acids, are otherwise not produced
by the body. Although the type of study we have undertaken provides
useful evidence of the degradation of dietary flavonoids and com-
pounds related to phenolic acids, a full elucidation of the pathways
involved awaits studies using stable isotope-labeled dietary fla-
vonoids. Finally, there is a growing awareness that colon-derived
phenolic acid may play a role in the potential protective effects of
FIG. 5. Proposed pathways for the conversion of punicalagin to ellagic acid and urolithins in anaerobic fecal suspensions.
TABLE 4
In vitro anaerobic metabolism of ellagic acid to urolithins in fecal suspensions from four donors
Quantities of substate and products detected in fecal samples taken 0, 6, 24, and 48 h after incubation of ellagic acid at a concentration 50 M. Data are expressed as mean values of
individual donors  S.E. (n  3).
Compounds 0 h 2 h 5 h 24 h 48 h 72 h
M
I
Ellagic acid 18  0 12  0 6.5  0.0 N.D. N.D. N.D.
Urolithin C N.D. N.D. 0.5  0.0 0.4  0.0 N.D. N.D.
Isourolithin A N.D. N.D. N.D. 8.5  0.3 10  0.1 12  0.2
Urolithin A N.D. N.D. N.D. 3.9  0.4 4.9  0.2 5.6  0.1
Urolithin B N.D. N.D. N.D. N.D. N.D. N.D.
Total urolithins N.D. N.D. 0.5  0.0 13  0.7 15  0 18  0
II
Ellagic acid 23  2 11  0 10  0 1.6  0.2 1.3  0.1 1.0  0.2
Urolithin C N.D. N.D. 0.7  0.0 16  0 11  0 1.1  0.0
Isourolithin A N.D. N.D. N.D. N.D. N.D. 0.9  0.0
Urolithin A N.D. N.D. N.D. 0.6  0.0 12  0.3 23  1
Urolithin B N.D. N.D. N.D. N.D. N.D. N.D.
Total urolithins N.D. N.D. 0.7  0.0 17  0 23  1 25  1
Ellagic acid 32  6 21  0 9.2  0.9 1.0  0.1 0.6  0.1 0.5  0.0
Urolithin C N.D. N.D. 0.9  0.0 14  0.3 9.0  0.1 6.7  0.1
Isourolithin A N.D. N.D. N.D. N.D. N.D. N.D.
Urolithin A N.D. N.D. N.D. 2.9  0.1 14  0 15  0
Urolithin B N.D. N.D. N.D. N.D. N.D. N.D.
Total urolithins N.D. N.D. 0.9  0.0 17  0 23  0 22  0
IV
Ellagic acid 40  1 30  0 13  0.7 0.9  0.2 N.D. N.D.
Urolithin C N.D. N.D. 0.3  0.0 8.3  0.3 0.1  0.0 N.D.
Isourolithin A N.D. N.D. N.D. 6.6  0.2 15  0.0 13  0.0
Urolithin A N.D. N.D. N.D. 4.1  0.2 7.8  0.2 8.2  0.1
Urolithin B N.D. N.D. N.D. N.D. 0.8  0.2 1.7  0.1
Total urolithins N.D. N.D. 0.3  0.0 19  0.7 23  1 23  0.3
N.D., not detected.
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dietary flavonoids and related compounds. Colonic catabolites from
(poly)phenolic compounds present in several fruits and beverages
have been shown to have antiglycative and neuroprotective effects
(Verzelloni et al., 2011), and phenolic catabolites are also reported to
have anti-inflammatory effects (Larrosa et al., 2009).
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